
Adapalene
Adapalene is a naphthoic acid that is CD437 in which the phenolic hydroxy group has been converted to its methyl ether. It has a role as a non-steroidal anti-inflammatory drug, a dermatologic drug and an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor. It is a monocarboxylic acid, a naphthoic acid and a member of adamantanes. It is functionally related to a CD437. — ChEBI
- IUPAC 名称
- 6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid
- 分子式
- C28H28O3
- 分子量
- 412.5 g/mol
- 精确质量
- 412.20384475 Da
- XLogP3
- 7.7
- 拓扑极性表面积
- 46.5 Ų
- 氢键供体
- 1
- 氢键受体
- 3
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:31174
- ChEMBL:CHEMBL1265
- ChEMBL:CHEMBL4303650
- EPA DTXSID:DTXSID5046481
- PubMed:24177211
- PubMed:22988653
- PubMed:22908733
- PubMed:22859236
- PubMed:22847319
- PubMed:22808305
- PubMed:22779096
- PubMed:22772617
- PubMed:22728381
- PubMed:22677304
- PubMed:22648218
- PubMed:22615511
来自其他科学数据库的证据
EMBL-EBI ChEBI
adapalene
A naphthoic acid that is CD437 in which the phenolic hydroxy group has been converted to its methyl ether.
- 配方
- C28H28O3
- 平均质量
- 412.529 g/mol
- 单同位素质量
- 412.20384 Da
- 形式电荷
- 0
- naphthoic acid — is a (CHEBI:25483)
- monocarboxylic acid — is a (CHEBI:25384)
- adamantanes — is a (CHEBI:51339)
- dermatologic drug — has role (CHEBI:50177)
- non-steroidal anti-inflammatory drug — has role (CHEBI:35475)
- EC 2.7.11.22 (cyclin-dependent kinase) inhibitor — has role (CHEBI:82665)
- CD437 — has functional parent (CHEBI:88334)
- dermatologic drug — has role (CHEBI:50177)
- non-steroidal anti-inflammatory drug — has role (CHEBI:35475)
- EC 2.7.11.22 (cyclin-dependent kinase) inhibitor — has role (CHEBI:82665)
- naphthoic acid — is a (CHEBI:25483)
- monocarboxylic acid — is a (CHEBI:25384)
- adamantanes — is a (CHEBI:51339)
- 11594670 来源: PubMed
- 12833014 来源: PubMed
- 16472241 来源: PubMed
- 18759424 来源: PubMed
- 22194678 来源: PubMed
- 23956101 来源: PubMed
- 25016424 来源: PubMed
- 25790278 来源: PubMed
- 26398439 来源: PubMed
- 26483036 来源: PubMed
- 29706423 来源: PubMed
- 30852084 来源: PubMed
- 34812616 来源: PubMed
- 35820623 来源: PubMed
- 37468498 来源: PubMed
- 8544175 来源: PubMed
其他整理的名称
来自此来源的交叉引用
映射方: Exact CAS cross-reference in the ChEBI compound record. 来源更新: 2017-02-22. 检索时间: 2026-08-31. 打开来源记录
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Boiling Point: 606.3 来源: DrugBank
- LogP: 6.917 来源: DrugBank
- LogP: 8.6 来源: Human Metabolome Database (HMDB)
- Melting Point: 300 来源: DrugBank
- Physical Description: Solid 来源: Human Metabolome Database (HMDB)
- Solubility: 4.01e-06 g/L 来源: Human Metabolome Database (HMDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). 来源: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Absorption of adapalene through human skin is low. Only trace amounts (<0.25 ng/mL) of parent substance have been found in the plasma of acne patients following chronic topical application of adapalene in controlled clinical trials 来源: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 9.1% (1 of 11) of reports. 来源: European Chemicals Agency (ECHA)
- Signal: Warning 来源: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (18.2%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (72.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (54.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (72.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (18.2%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H361 (81.8%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] 来源: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P261, P264, P264+P265, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 11 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 11 reports by companies.; There are 6 notifications provided by 10 of 11 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
- Health Effects: Chronic ingestion of the drug may lead to the same side effects as those associated with excessive oral intake of Vitamin A. 来源: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: If the adapalene is applied excessively, marked redness, scaling, or skin discomfort may occur. In addition, according to product labeling, chronic ingestion of the drug may lead to the same adverse drug reactions associated with excessive oral intake of vitamin A. 来源: StatPearls
- Toxicity Summary: Mechanistically, adapalene binds to specific retinoic acid nuclear receptors (gamma and beta) and retinoid X receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation. 来源: Toxin and Toxin Target Database (T3DB)
- Uses: Use (kg) in USA (2002): 78; Consumption (g per capita) in the USA (2002): 0.000278; Calculated removal (%): 97.7 来源: NORMAN Suspect List Exchange
- Uses: For the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back. 来源: Toxin and Toxin Target Database (T3DB)
映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录
科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。
其他来源的覆盖范围和匹配状态
| 来源 | 结果 | 已检查 |
|---|---|---|
| EMBL-EBI ChEBI | 精确匹配 | 2026-08-31 |
| NIH PubChem PUG-View | 精确匹配 | 2026-08-31 |
已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。